Newsletter #4 for September 22nd, 2021

Pfizer booster gets FDA emergency use authorization today, and inflammation dominates the theme of tonight's letter.

Key News Item

* While I was working late tonight, I learned that the FDA has extended its emergency use authorization to allow higher-risk people to receive the much-anticipated Pfizer booster shots already being given in other countries like Israel, Germany, France, and Britain. Moderna and J&J recipients will likely receive the same privilege soon.

I…